Th e Unfortunate Research Inertia on Studying VTE in Nursing Homes
To the Editor:
We read with great interest the recent article by Leibson et al 1 in CHEST (August 2014) on prophylaxis of VTE in nursing home residents. Th e article eloquently describes the dilemma of VTE in daily clinical care in nursing homes. Many nursing home residents will be at increased risk of VTE, yet these very same factors that drive this risk also increase the potential of serious bleeding complications should VTE prophylaxis or treatment be initiated.
VTE research by itself is hugely popular-as exemplifi ed by the staggering number of nearly 130,000 hits in PubMed using search terms for VTE. Unfortunately, however, only an alarmingly low number of 79 of these articles study VTE in a nursing home setting. We, therefore, welcome the article by Leibson et al, 1 as it clearly shows us that evidence (and, thus, also guidelines) from a non-nursing home setting cannot easily be transferred to nursing homes, given the diff erences in VTE risk factors as they described. In a recent publication from our group, we found similar issues regarding the diffi culty of transferring evidence. 2 In a sample of 423 nursing home residents with suspected VTE, 322 patients were at high risk based on a clinical decision rule combined with D-dimer testing. Of these patients, 126 (39%) were not referred for additional imaging, despite the fact that guidelines for non-nursing homes currently recommend doing so. We evaluated reasons for these nonreferral decisions as well as their consequences. Physicians reported that advance care planning and the estimated impact on life expectancy of concurrent comorbidity (including, thus, the relative merits of further diagnostic investigations) played a role in these nonreferral decisions. Nonreferral was associated with higher risk of mortality (crude OR, 2.45; 95% CI, 1.40-4.29), yet this OR no longer reached signifi cance when adjusted for comorbidity (using propensity scores estimating the probability of referral).
Clearly, both the study from Leibson et al 1 as well as our own recent observation 2 stress the need for more research in this fi eld. Th is should provide answers to relatively simple questions: "What are the potential benefi ts of VTE prophylaxis in high-risk patients residing in nursing homes?" or "What diagnostic tests should I perform when VTE is suspected in a nursing home patient, and what are the net clinical benefi ts of referral?" Th ese are questions that long have been answered in a non-nursing home setting yet still remain largely unanswered for this specifi c clinical domain.
